← Back
Cerense
72 new bond street, w1s 1rr
mayfair, london
Business profile
CerenseSM will greatly help the development and provision of new, safe and effective medicines for CNS disorders such as Alzheimer's disease and Parkinson's disease. CerenseSM is available exclusively through a partnership between and We are delighted to work with Pharmidex to create a platform that we believe will have a meaningful impact on the creation of new drugs for central nervous system disorders," said Dan Hayden, Senior Vice President and General Manager of Genzyme Pharmaceuticals
Customer reviews
No reviews yet
Write a review